China Universal China Universal Hang Seng H K - Listed Biotechnology Index ETF (SHA:513280)
1.324
-0.020 (-1.49%)
At close: Sep 23, 2025
SHA:513280 Holdings Information
SHA:513280 is an equity ETF with a total of 53 individual holdings. The top holdings are Innovent Biologics stock at 10.91%, WuXi Biologics at 9.35%, BeOne Medicines AG at 8.85%, CSPC Pharmaceutical Group at 6.13%, and Akeso at 6.08%.
Total Holdings
53
Top 10 Percentage
60.73%
Asset Class
Equity
ETF Category
Health Care
Assets
n/a
PE Ratio
13.75
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | HKG: 1801 | Innovent Biologics, Inc. | 10.91% |
2 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 9.35% |
3 | HKG: 6160 | BeOne Medicines AG | 8.85% |
4 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 6.13% |
5 | HKG: 9926 | Akeso, Inc. | 6.08% |
6 | HKG: 1177 | Sino Biopharmaceutical Limited | 5.35% |
7 | HKG: 1530 | 3SBio Inc. | 4.47% |
8 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 3.47% |
9 | n/a | Cash | 3.16% |
10 | HKG: 9688 | Zai Lab Limited | 2.97% |
11 | HKG: 2359 | WuXi AppTec Co., Ltd. | 2.70% |
12 | HKG: 2367 | Giant Biogene Holding Co., Ltd. | 2.65% |
13 | HKG: 6618 | JD Health International Inc. | 2.37% |
14 | HKG: 1548 | Genscript Biotech Corporation | 2.04% |
15 | HKG: 6855 | Ascentage Pharma Group International | 1.84% |
16 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 1.69% |
17 | HKG: 0867 | China Medical System Holdings Limited | 1.59% |
18 | HKG: 9969 | InnoCare Pharma Limited | 1.54% |
19 | HKG: 0241 | Alibaba Health Information Technology Limited | 1.50% |
20 | HKG: 1066 | Shandong Weigao Group Medical Polymer Company Limited | 1.50% |
21 | HKG: 3933 | The United Laboratories International Holdings Limited | 1.48% |
22 | HKG: 1952 | Everest Medicines Limited | 1.40% |
23 | HKG: 0512 | Grand Pharmaceutical Group Limited | 1.37% |
24 | 13.HK | HUTCHMED (China) Ltd | 1.31% |
25 | HKG: 2268 | WuXi XDC Cayman Inc. | 1.23% |
As of Jun 30, 2025